Corresponding Author: Douglas K. Owens, MD, MS, Stanford University, 615 Crothers Way, Encina Commons, Mail Code 6019, Stanford, CA 94305-6006 (email@example.com).
The US Preventive Services Task Force (USPSTF) members: Douglas K. Owens, MD, MS; Karina W. Davidson, PhD, MASc; Alex H. Krist, MD, MPH; Michael J. Barry, MD; Michael Cabana, MD, MA, MPH; Aaron B. Caughey, MD, PhD; Susan J. Curry, PhD; Katrina Donahue, MD, MPH; Chyke A. Doubeni, MD, MPH; John W. Epling Jr, MD, MSEd; Martha Kubik, PhD, RN; Gbenga Ogedegbe, MD, MPH; Lori Pbert, PhD; Michael Silverstein, MD, MPH; Melissa A. Simon, MD, MPH; Chien-Wen Tseng, MD, MPH, MSEE; John B. Wong, MD.
Affiliations of The US Preventive Services Task Force (USPSTF) members: Veterans Affairs Palo Alto Health Care System, Palo Alto, California (Owens); Stanford University, Stanford, California (Owens); Feinstein Institute for Medical Research at Northwell Health, Manhasset, New York (Davidson); Fairfax Family Practice Residency, Fairfax, Virginia (Krist); Virginia Commonwealth University, Richmond (Krist); Harvard Medical School, Boston, Massachusetts (Barry); University of California, San Francisco (Cabana); Oregon Health & Science University, Portland (Caughey); University of Iowa, Iowa City (Curry); University of North Carolina at Chapel Hill (Donahue); Mayo Clinic, Rochester, Minnesota (Doubeni); Virginia Tech Carilion School of Medicine, Roanoke (Epling Jr); Temple University, Philadelphia, Pennsylvania (Kubik); New York University, New York, New York (Ogedegbe); University of Massachusetts Medical School, Worcester (Pbert); Boston University, Boston, Massachusetts (Silverstein); Northwestern University, Evanston, Illinois (Simon); University of Hawaii, Honolulu (Tseng); Pacific Health Research and Education Institute, Honolulu, Hawaii (Tseng); Tufts University School of Medicine, Boston, Massachusetts (Wong).
Author Contributions: Dr Owens had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. The USPSTF members contributed equally to the recommendation statement.
Conflict of Interest Disclosures: Authors followed the policy regarding conflicts of interest described at https://www.uspreventiveservicestaskforce.org/Page/Name/conflict-of-interest-disclosures. All members of the USPSTF receive travel reimbursement and an honorarium for participating in USPSTF meetings. Dr Barry reported receiving grants and personal fees from Healthwise.
Funding/Support: The USPSTF is an independent, voluntary body. The US Congress mandates that the Agency for Healthcare Research and Quality (AHRQ) support the operations of the USPSTF.
Role of the Funder/Sponsor: AHRQ staff assisted in the following: development and review of the research plan, commission of the systematic evidence review from an Evidence-based Practice Center, coordination of expert review and public comment of the draft evidence report and draft recommendation statement, and the writing and preparation of the final recommendation statement and its submission for publication. AHRQ staff had no role in the approval of the final recommendation statement or the decision to submit for publication.
Disclaimer: Recommendations made by the USPSTF are independent of the US government. They should not be construed as an official position of AHRQ or the US Department of Health and Human Services.
Additional Contributions: We thank Tina Fan, MD, MPH (AHRQ), who contributed to the writing of the manuscript, and Lisa Nicolella, MA (AHRQ), who assisted with coordination and editing.
Additional Information: The USPSTF makes recommendations about the effectiveness of specific preventive care services for patients without obvious related signs or symptoms. It bases its recommendations on the evidence of both the benefits and harms of the service and an assessment of the balance. The USPSTF does not consider the costs of providing a service in this assessment. The USPSTF recognizes that clinical decisions involve more considerations than evidence alone. Clinicians should understand the evidence but individualize decision-making to the specific patient or situation. Similarly, the USPSTF notes that policy and coverage decisions involve considerations in addition to the evidence of clinical benefits and harms.
US Department of Health and Human Services. The Health Consequences of Smoking: 50 Years of Progress: A Report of the Surgeon General. US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2014.
US Department of Health and Human Services. E-Cigarette Use Among Youth and Young Adults: A Report of the Surgeon General. Office of the Surgeon General; 2016.
KA , Ambrose
BK , Gentzke
AS , Apelberg
BJ , Jamal
A , King
BA . Notes from the field: use of electronic cigarettes and any tobacco product among middle and high school students—United States, 2011-2018. MMWR Morb Mortal Wkly Rep
. 2018;67(45):1276-1277. doi:10.15585/mmwr.mm6745a5PubMedGoogle ScholarCrossref
National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Population Health and Public Health Practice; Committee on the Review of the Health Effects of Electronic Nicotine Delivery Systems. Public Health Consequences of E-Cigarettes. National Academies Press; 2018.
NA , Mansvelder
HD . Short- and long-term consequences of nicotine exposure during adolescence for prefrontal cortex neuronal network function. Cold Spring Harb Perspect Med
. 2012;2(12):a012120. doi:10.1101/cshperspect.a012120PubMedGoogle Scholar
S , Patnode
C , Bailey
et al Primary Care Relevant Interventions for Tobacco and Nicotine Use Prevention and Cessation in Children and Adolescents: A Systematic Review for the U.S. Preventive Services Task Force: Evidence Synthesis No. 185. Agency for Healthcare Research and Quality; 2020. AHRQ publication 19-05254-EF-1.
S , Patnode
C , Bailey
SR , Pappas
M , Stoner
R , Chou
R . Primary care–relevant interventions for tobacco and nicotine use prevention and cessation in children and adolescents: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA
. Published April 28, 2020. doi:10.1001/jama.2020.3332Google Scholar
AL ; US Preventive Services Task Force. Behavioral and pharmacotherapy interventions for tobacco smoking cessation in adults, including pregnant women: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med
. 2015;163(8):622-634. doi:10.7326/M15-2023PubMedGoogle ScholarCrossref
LD , Miech
RA , O’Malley
PM , Bachman
JG , Schulenberg
JE , Patrick
ME . Monitoring the Future: National Survey Results on Drug Use 1975-2018: 2018 Overview: Key Findings on Adolescent Drug Use
. Institute for Social Research, University of Michigan; 2019. doi:10.3998/2027.42/150621
JF , Polen
MR , Whitlock
et al. Teen reach: outcomes from a randomized, controlled trial of a tobacco reduction program for teens seen in primary medical care. Pediatrics
. 2005;115(4):981-989. doi:10.1542/peds.2004-0981PubMedGoogle ScholarCrossref
M , Mesters
I , van Breukelen
G , De Vries
H . Short-term effects of a randomized computer-based out-of-school smoking prevention trial aimed at elementary schoolchildren. Prev Med
. 2002;34(6):581-589. doi:10.1006/pmed.2002.1021PubMedGoogle ScholarCrossref
M , Ringlever
L , Otten
R , van Schayck
OC , Jackson
C , Engels
RC . Long-term effects of a home-based smoking prevention program on smoking initiation: a cluster randomized controlled trial. Prev Med
. 2014;60:65-70. doi:10.1016/j.ypmed.2013.12.012PubMedGoogle ScholarCrossref
L , Flint
AJ , Fletcher
KE , Young
MH , Druker
S , DiFranza
JR . Effect of a pediatric practice-based smoking prevention and cessation intervention for adolescents: a randomized, controlled trial. Pediatrics
. 2008;121(4):e738-e747. doi:10.1542/peds.2007-1029PubMedGoogle ScholarCrossref
HA , Hennrikus
D , Boyle
R , Lazovich
D , Stafne
E , Rindal
B . Promoting tobacco abstinence among older adolescents in dental clinics. J Smok Cessat
. 2007;2(1):23-30. doi:10.1375/jsc.2.1.23Google ScholarCrossref
CA , Prochaska
JO , Armstrong
et al. Randomized trial outcomes of a TTM-tailored condom use and smoking intervention in urban adolescent females. Health Educ Res
. 2015;30(1):162-178. doi:10.1093/her/cyu015PubMedGoogle ScholarCrossref
HP , Mercken
L , Candel
M , de Vries
H , Oenema
A . A Web-based, computer-tailored smoking prevention program to prevent children from starting to smoke after transferring to secondary school: randomized controlled trial. J Med Internet Res
. 2015;17(3):e59. doi:10.2196/jmir.3794PubMedGoogle Scholar
TC , Glasziou
PP , Boutron
et al. Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. BMJ
. 2014;348:g1687. doi:10.1136/bmj.g1687PubMedGoogle ScholarCrossref
VA ; US Preventive Services Task Force. Primary care behavioral interventions to reduce illicit drug and nonmedical pharmaceutical use in children and adolescents: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med
. 2014;160(9):634-639. doi:10.7326/M14-0334PubMedGoogle ScholarCrossref
US Department of Health and Human Services. Preventing Tobacco Use Among Youth and Young Adults: A Report of the Surgeon General. Centers for Disease Control and Prevention; 2012.
CS , van den Eijnden
RJ , Engels
RC , Vollebergh
WA . Short-term efficacy of nicotine replacement therapy for smoking cessation in adolescents: a randomized controlled trial. J Subst Abuse Treat
. 2014;46(2):120-127. doi:10.1016/j.jsat.2013.08.008PubMedGoogle ScholarCrossref
VA ; US Preventive Services Task Force. Primary care interventions to prevent tobacco use in children and adolescents: U.S. Preventive Services Task Force recommendation statement. Pediatrics
. 2013;132(3):560-565. doi:10.1542/peds.2013-2079PubMedGoogle ScholarCrossref
ML , Leischow
SJ , Sherrill
D , Matthews
E , Strayer
LJ . Randomized, double-blind, placebo-controlled trial of 2 dosages of sustained-release bupropion for adolescent smoking cessation. Arch Pediatr Adolesc Med
. 2007;161(11):1068-1074. doi:10.1001/archpedi.161.11.1068PubMedGoogle ScholarCrossref
KM , Baker
NL , McClure
et al. Efficacy and safety of varenicline for adolescent smoking cessation: a randomized clinical trial. JAMA Pediatr
. Published online October 14, 2019 doi:10.1001/jamapediatrics.2019.3553Google Scholar
US Department of Health and Human Services. Smoking Cessation: A Report of the Surgeon General. US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2020.